Recent Articles

The Efficacy and Safety of Levosimendan on Patients with Refractory Heart Failure (ReHF): A systematic review and meta-analysis

PDF FullText DOI: 10.52338/Jocd.2022.1006

The Role of PVI in the Evolution of AF Ablation Strategies

PDF FullText DOI: 10.52338/Jocd.2022.1005

The UHS is one of the most important risk factors for atherosclerosis and metabolic syndrome

PDF FullText DOI: 10.52338/Jocd.2022.1004

Impenem+Cilastatin interfering with creatinine estimation in Jaffe’s Kinetic method

PDF FullText DOI: 10.52338/Jocd.2022.1003

An operating image of an extreme case of hypoplastic left heart syndrome for instructional purposes.

PDF FullText DOI: 10.52338/Jocd.2022.1002

The mechanism of diabetes is explained by a new cardiovascular disease (CVD)/cancer theory

PDF FullText DOI: 10.52338/Jocd.2021.1001

Journal Info

  • Journal Name: Journal of Cardiovascular Diseases
  • Impact Factor: 2.08*
  • ISSN: 2831-3437
  • DOI: 10.52338/Jocd
  • Short Name: Jocd
  • Acceptance rate: 55%
  • Volume: 6 (2024)
  • Submission to acceptance: 25 days
  • Acceptance to publication: 10 days


  • Crossref indexed journal
  • Publons indexed journal
  • Pubmed-indexed journal
  • International Scientific Indexing (ISI)-indexed journal
  • Eurasian Scientific Journal Index (ESJI) index journal
  • Semantic Scholar indexed journal
  • Cosmos indexed journal


  • International Reach
  • Peer Review
  • Rapid Publication
  • Open Access
  • High Visibility